BSE: STAR - Strides Pharma Science Limited

Lønnsomhet i seks måneder: -27.91%

Kampanjeplan Strides Pharma Science Limited

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams.

flere detaljer
It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

EBITDA 3.77
EV/EBITDA 12.02
ISIN INE939A01011
Industry Pharmaceuticals
P/BV 1.06
P/E 75.66
P/S 1.02
Sector Health Care
Валюта inr
Валюта отчета inr
Выручка 27.07
Див.доход ао 0
Дивиденд ао 1.5
Сайт https://www.strides.com
Цена ао 1324.6
Число акций ао 0.0903 млрд
Prisendring per dag: +0.4362% (676.3)
Prisendring per uke: -0.738% (684.3)
Prisendring per måned: -55.54% (1527.7)
Prisendring over 3 måneder: -51.81% (1409.6)
Prisendring over seks måneder: -27.91% (942.2)
Prisendring per år: +5.8% (642)
Prisendring over 3 år: +62.44% (418.15)
Prisendring over 5 år: +75.79% (386.4)
Prisendring over 10 år: 0% (679.25)
Prisendring siden begynnelsen av året: -1.6% (690.3)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 1.76 8
P/BV 3.44 5
P/E 0 0
EV/EBITDA 22.91 5
Total: 5.5

Effektivitet

Navn Betydning Karakter
ROA, % -1.13 0
ROE, % -3.26 0
Total: 0.6667

Utbytte

Navn Betydning Karakter
Div yield, % 0.0512 0.13
DSI 0.8571 8.57
Total: 1.79

Plikt

Navn Betydning Karakter
Debt/EBITDA 11.07 0
Total: 5.8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 49.63 6
Lønnsomhet Ebitda, % -46.65 0
Lønnsomhet EPS, % -289.02 0
Total: 3.2
Flere detaljer

Veileder Stillingstittel Betaling Fødselsår
Mr. Arun Kumar Pillai B.Com. Founder & Executive Chairperson 60M 1961 (64 år)
Mr. Badree Komandur MD & Group CEO 44M 1972 (53 år)
Ms. Manjula Ramamurthy Compliance Officer & Company Secretary N/A
Sormistha Ghosh Group General Counsel, Chief Risk Officer & Chief Sustainability Officer N/A
Mr. C. K. Sundar Executive Vice President of Operations N/A
Mr. Kevin P. Cook Senior Vice President of Strides Pharma Inc. N/A
Mr. P. V. S. Ramaraju Chief Operating Officer N/A
Mr. Aditya Arun Kumar Executive Director of Business Development & Director
Mr. Vikesh Kumar Group CFO & Chief Investor Relations Officer 1985 (40 år)
Ms. Surabhi Loshali Group Chief Human Resource Officer 1980 (45 år)

Adresse: India, Bengaluru, Strides House - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.strides.com